These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 26485258)
21. Effectiveness of twice a week prophylaxis with atovaquone-proguanil (Malarone®) in long-term travellers to West Africa. Lachish T; Bar-Meir M; Eisenberg N; Schwartz E J Travel Med; 2016 Jun; 23(6):. PubMed ID: 27625401 [TBL] [Abstract][Full Text] [Related]
22. Molecular characterization of the cytochrome b gene and in vitro atovaquone susceptibility of Plasmodium falciparum isolates from Kenya. Ingasia LA; Akala HM; Imbuga MO; Opot BH; Eyase FL; Johnson JD; Bulimo WD; Kamau E Antimicrob Agents Chemother; 2015 Mar; 59(3):1818-21. PubMed ID: 25583715 [TBL] [Abstract][Full Text] [Related]
23. Malarone treatment failure not associated with previously described mutations in the cytochrome b gene. Wichmann O; Muehlen M; Gruss H; Mockenhaupt FP; Suttorp N; Jelinek T Malar J; 2004 Jun; 3():14. PubMed ID: 15186499 [TBL] [Abstract][Full Text] [Related]
24. Randomised placebo-controlled study of atovaquone plus proguanil for malaria prophylaxis in children. Lell B; Luckner D; Ndjavé M; Scott T; Kremsner PG Lancet; 1998 Mar; 351(9104):709-13. PubMed ID: 9504515 [TBL] [Abstract][Full Text] [Related]
25. Atovaquone and proguanil hydrochloride for prophylaxis of malaria. Shanks GD; Kremsner PG; Sukwa TY; van der Berg JD; Shapiro TA; Scott TR; Chulay JD; J Travel Med; 1999 May; 6 Suppl 1():S21-7. PubMed ID: 23573549 [TBL] [Abstract][Full Text] [Related]
27. Comparative benefit of malaria chemoprophylaxis modelled in United Kingdom travellers. Toovey S; Nieforth K; Smith P; Schlagenhauf P; Adamcova M; Tatt I; Tomianovic D; Schnetzler G Travel Med Infect Dis; 2014; 12(6 Pt B):726-32. PubMed ID: 25443997 [TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of atovaquone-proguanil in treating imported malaria in Japan: the second report from the research group. Kimura M; Koga M; Kikuchi T; Miura T; Maruyama H Parasitol Int; 2012 Sep; 61(3):466-9. PubMed ID: 22484597 [TBL] [Abstract][Full Text] [Related]
29. Malarone treatment failure and in vitro confirmation of resistance of Plasmodium falciparum isolate from Lagos, Nigeria. Fivelman QL; Butcher GA; Adagu IS; Warhurst DC; Pasvol G Malar J; 2002 Feb; 1():1. PubMed ID: 12057021 [TBL] [Abstract][Full Text] [Related]
30. Molecular surveillance of mutations in the cytochrome b gene of Plasmodium falciparum in Gabon and Ethiopia. Gebru T; Hailu A; Kremsner PG; Kun JF; Grobusch MP Malar J; 2006 Nov; 5():112. PubMed ID: 17118179 [TBL] [Abstract][Full Text] [Related]
31. A cluster of Plasmodium vivax malaria in an expedition group to Ethiopia: prophylactic efficacy of atovaquone/proguanil on liver stages of P. vivax. Mavrogordato A; Lever AM J Infect; 2012 Sep; 65(3):269-74. PubMed ID: 22609735 [TBL] [Abstract][Full Text] [Related]
32. Early treatment failure during treatment of Plasmodium falciparum malaria with atovaquone-proguanil in the Republic of Ivory Coast. Wurtz N; Pascual A; Marin-Jauffre A; Bouchiba H; Benoit N; Desbordes M; Martelloni M; Pommier de Santi V; Richa G; Taudon N; Pradines B; Briolant S Malar J; 2012 May; 11():146. PubMed ID: 22551095 [TBL] [Abstract][Full Text] [Related]
33. Plasmodium chabaudi chabaudi malaria parasites can develop stable resistance to atovaquone with a mutation in the cytochrome b gene. Afonso A; Neto Z; Castro H; Lopes D; Alves AC; Tomás AM; Rosário VD Malar J; 2010 May; 9():135. PubMed ID: 20492669 [TBL] [Abstract][Full Text] [Related]
34. Impact of Chemoprophylaxis on Plasmodium vivax and Plasmodium ovale Infection Among Civilian Travelers: A Nested Case-Control Study With a Counterfactual Approach on 862 Patients. Le Goff M; Kendjo E; Thellier M; Piarroux R; Boelle PY; Jauréguiberry S; Clin Infect Dis; 2023 Feb; 76(3):e884-e893. PubMed ID: 35962785 [TBL] [Abstract][Full Text] [Related]
35. Randomized trial of artesunate-amodiaquine, atovaquone-proguanil, and artesunate-atovaquone-proguanil for the treatment of uncomplicated falciparum malaria in children. Tahar R; Almelli T; Debue C; Foumane Ngane V; Djaman Allico J; Whegang Youdom S; Basco LK J Infect Dis; 2014 Dec; 210(12):1962-71. PubMed ID: 24943722 [TBL] [Abstract][Full Text] [Related]
36. Analyses of cytochrome b mutations in Plasmodium falciparum isolates in Thai-Myanmar border. Naoshima-Ishibashi Y; Iwagami M; Kawazu S; Looareesuwan S; Kano S Travel Med Infect Dis; 2007 Mar; 5(2):132-4. PubMed ID: 17298921 [TBL] [Abstract][Full Text] [Related]
38. Emergence of resistance to atovaquone-proguanil in malaria parasites: insights from computational modeling and clinical case reports. Cottrell G; Musset L; Hubert V; Le Bras J; Clain J; Antimicrob Agents Chemother; 2014 Aug; 58(8):4504-14. PubMed ID: 24867967 [TBL] [Abstract][Full Text] [Related]
39. Effectiveness of malaria chemoprophylaxis against Plasmodium falciparum infection in UK travellers: retrospective observational data. Zuckerman JN; Batty AJ; Jones ME Travel Med Infect Dis; 2009 Nov; 7(6):329-36. PubMed ID: 19945009 [TBL] [Abstract][Full Text] [Related]
40. [Tolerance and efficacy of atovaquone-proguanil for the treatment of paediatric imported Plasmodium falciparum malaria in France: clinical practice in a university hospital in Paris]. Blondé R; Naudin J; Bigirimana Z; Holvoet L; Fenneteau O; Vitoux C; Bourdon O; Angoulvant F; Lorrot M; D'Ortenzio E; Bourrillon A; Le Bras J; Matheron S; Faye A Arch Pediatr; 2008 Mar; 15(3):245-52. PubMed ID: 18321692 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]